Related Experiment Videos
Features of recurrent brief depression
1St Mary's Hospital School, London, UK.
Abstract:
Recurrent brief depression, characterised by frequently occurring brief depressive episodes, lasting less than two weeks, is now recognised as a common and disabling illness with a chronic relapsing course and a significant suicide risk. The episodes have a mean duration of 3 days, but otherwise fulfill the symptomatic criteria for DSM III-R major depression. Some two thirds of episodes satisfy severity criteria for at least moderate depression and about a third for severe depression. They recur erratically with a mean period of 18 days between the start of one episode and the next. Because of the frequency of the episodes patients may report longer continuous periods of depression than was the case and may be mistakenly perceived as dysthymia as major depression. It is important to identify these patients as treatment response appears to differ. The episodes are too short to be able to assume efficacy with conventional antidepressants; it is necessary to adopt a prophylactic strategy for treatment aiming to reduce the severity, the frequency, or the duration of episodes.
Insights
Recurrent brief depression involves frequent, short depressive episodes, often mistaken for other conditions. Prophylactic treatment is essential due to its chronic nature and suicide risk.
Area of Science:
- Psychiatry and Mental Health
- Clinical Psychology
- Epidemiology of Mood Disorders
Background:
- Recurrent brief depression (RBD) is a prevalent, disabling condition characterized by frequent, short depressive episodes.
- These episodes, typically lasting less than two weeks (mean 3 days), meet diagnostic criteria for major depression.
- RBD has a chronic, relapsing course and is associated with significant suicide risk.
Purpose of the Study:
- To highlight the distinct nature of recurrent brief depression and its diagnostic challenges.
- To emphasize the importance of identifying RBD patients due to potentially different treatment responses.
- To advocate for a shift in treatment strategy for RBD.
Main Methods:
- Analysis of episode duration, frequency, and severity based on diagnostic criteria (DSM III-R).
- Comparison of patient-reported continuous depression periods versus actual episodic nature.
- Evaluation of treatment efficacy considerations for short-duration depressive episodes.
Main Results:
- Episodes of RBD have a mean duration of 3 days and recur erratically, with a mean inter-episode period of 18 days.
- Approximately two-thirds of episodes meet criteria for at least moderate depression, and one-third for severe depression.
- Patients may be misdiagnosed with dysthymia due to the cumulative effect of frequent, short episodes.
Conclusions:
- Recurrent brief depression is a distinct clinical entity requiring specific diagnostic consideration.
- Conventional antidepressant monotherapy may be insufficient due to the short episode duration.
- A prophylactic treatment strategy is necessary to reduce episode severity, frequency, or duration in RBD.